openPR Logo
Press release

Breast Cancer Drug Market Growing Popularity and Emerging Trends | Celldex Therapeutics, MacroGenics, Inc., Hoffmann-La Roche Ltd

05-07-2020 10:00 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Breast Cancer Drug Market

Breast Cancer Drug Market

Global Breast Cancer Drug Market is rise gradually to an estimated value of USD 43.63 Billion by 2026 registering a CAGR of 11.1% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.

The Breast Cancer Drug market report includes data on consumer perspective, comprehensive analysis, statistics, market share, corporate performance (stocks), historical analysis from 2019 to 2026, volume forecast, revenue, the growth rate of 2026 and growth rate of CAGR.

Download Sample PDF Report: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-breast-cancer-drug-market

Key Players -

AbbVie Inc (US)
AstraZeneca Plc (UK)
Celgene Corporation (US)
Merck & Co., Inc. (US)
Celldex Therapeutics (US)
MacroGenics, Inc. (US)
Hoffmann-La Roche Ltd (Switzerland)
Merck KGaA (Germany)
Bristol-Myers Squibb Company (US)
Novartis AG (Switzerland)
Eli Lilly and Company (US)
Sanofi S.A (France) and few among others.

Market Drivers

Increase in prevalence rate of breast cancer drug worldwide.
Increase treatment rate.
Early detection of breast cancer.
Effective surgical and medical treatment.
Rising awareness about treatment and technological advancement is driving the growth of market.
Increase in the rate of R&D initiatives is driving Breast Cancer Drug therapeutics market.

Market Restraints

High cost involved in the treatment.
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market.
Lack of awareness among the patient and physician about Breast Cancer treatment.

Key Developments in the Market:

On 11 Mar 2019, F. Hoffmann-La Roche Ltd received accelerated approval for Tecentriq (atezolizumab ) in combination with Abraxane for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC).

On 28 Feb 2019, F. Hoffmann-La Roche Ltd received FDA approval for the Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) in combination with chemotherapy which is administered through subcutaneous route for the treatment of HER2-positive breast cancer.

On 26 Apr 2019, Pfizer Inc. received positive CHMP of European Medicines Agency (EMA) opinion for Talzenna (talazoparib) for the treatment of patients with germline breast cancer susceptibility gene (gBRCA)1/2-mutations, who have human epidermal growth factor receptor 2-negative (HER2-) locally advanced (LA) or metastatic breast cancer (MBC) provided that patient previously treated with an anthracycline and/or a taxane medication.

Table of Content:

Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Global Breast Cancer Drug Market Landscape
Part 04: Global Breast Cancer Drug Market Sizing
Part 05: Global Breast Cancer Drug Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Get Detailed TOC: https://databridgemarketresearch.com/toc/?dbmr=global-breast-cancer-drug-market

Segmentation: Global Breast Cancer Drug Market

By Mechanism of Cation Type

HER2 Inhibitors
Mitotic Inhibitors
Anti-metabolites
Aromatase Inhibitors
CDK 4/6 Inhibitors
Hormonal Receptor

By Type

Ductal Carcinoma In Situ (DCIS)
Invasive Ductal Carcinoma (IDC)
Tubular Carcinoma of the Breast
Medullary Carcinoma of the Breast
Mucinous Carcinoma of the Breast
Papillary Carcinoma of the Breast
Cribriform Carcinoma of the Breast
Invasive Lobular Carcinoma (ILC)
Inflammatory Breast Cancer
Lobular Carcinoma In Situ (LCIS)
Male Breast Cancer
Molecular Subtypes of Breast Cancer
Paget's Disease of the Nipple
Phyllodes Tumors of the Breast
Metastatic Breast Cancer
Others

By Stage

T: Primary Tumor Size
N: Lymph Node Involvement
M: Cancer spread beyond the breast and lymph nodes

By Drug Type

Herceptin Hylecta
Atezolizumab
Talazoparib
Ribociclib
Abemaciclib
Neratinib
Palbociclib
Others

By Therapy Type

Medication
Chemotherapy
Targeted Therapy
Surgery

By Route of administration

Oral
Injectable

By End users

Hospitals
Homecare
Specialty Clinics
Others

On the basis of geography, the global sandboxing market report covers data points for 28 countries across multiple geographies such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Competitive Analysis:

Global breast cancer drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of breast cancer drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Inquiry Before Buying: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-breast-cancer-drug-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast Cancer Drug Market Growing Popularity and Emerging Trends | Celldex Therapeutics, MacroGenics, Inc., Hoffmann-La Roche Ltd here

News-ID: 2037309 • Views:

More Releases from Data Bridge Market Research

Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Preparative and Process Chromatography Market CAGR of 8.8% by 2029, Size, Share, …
"Preparative and Process Chromatography Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis.
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Neonatal Seizures Drugs Market CAGR of 3.40% by 2029, Size, Share, Trends, Deman …
"Global Sodium Lactate Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. The document also explains key elements such as revenue, business distribution, market share, shipment, gross profit, and more. All these elements help the readers to understand more information about industry competitors. Being the most suitable example of the above attributes, the
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Cold Chain Monitoring Components Market CAGR of 15.3% by 2028, Size, Share, Tren …
Data Bridge Market research has recently released expansive research titled Global Cold Chain Monitoring Components Market guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
Sodium Hypophosphite: Unveiling the Power of this Essential Chemical Compound
The rise in demand for water treatment in industrial applications across the globe acts as one of the major factors driving the growth of sodium hypophosphite market. The rise in usage of sodium hypophosphite in the electroplating application as reducing agents, and increase in electroplating of metal surface assist in enhancing properties such as abrasion resistance, hardness, corrosion resistance, and strength among others accelerate the market growth. The increase in

All 5 Releases


More Releases for Breast

Breast Ultrasound Market Research Report and Forecast to 2028 - Conventional Bre …
A breast ultrasound is an imaging method chiefly utilized to screen for tumours and other breast abnormalities. The ultrasound use high-frequency sound waves for the production of detailed images of the inside of the breasts. The global Breast Ultrasound Market is expected to grow at a significant CAGR of 14.6% by 2028. The updated report on the Breast Ultrasound market gives a precise analysis of the value chain assessment for the review
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. Download Free PDF Brochure on Brest Imaging Market Report Now
Breast Implants Market Report 2018: Segmentation by Product (Silicone Breast Imp …
Global Breast Implants market research report provides company profile for Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to
Automated Breast Ultrasound Systems – The Future of Breast Screening
Breast cancer is the most commonly diagnosed type of cancer and the second leading cause of death among women, as evident from stats revealed by the National Breast Cancer Foundation. Growing awareness of breast cancer has increased number of women undergoing breast screening and in turn would propel demand for automated breast ultrasound systems (ABUS) in hospitals and diagnostic centers. ABUS enables physicians to screen women, especially with denser breasts
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed? Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can